Pw. Berman et Gr. Nakamura, ADHESION MEDIATED BY INTERCELLULAR-ADHESION MOLECULE-1 ATTENUATES THEPOTENCY OF ANTIBODIES THAT BLOCK HIV-1 GP160-DEPENDENT SYNCYTIUM FORMATION, AIDS research and human retroviruses, 10(5), 1994, pp. 585-593
Several lines of evidence suggest that leukocyte adhesion molecules ca
n promote HIV-1-mediated cell fusion and syncytium formation. In the p
resent studies, the human kidney cell line, 293, was transfected with
the envelope glycoprotein gene of the MN strain of HIV-I alone or cotr
ansfected with a cDNA encoding intercellular adhesion molecule 1 (ICAM
-1). It was found that 293 cells transfected with the HIV-1(MN)env gen
e expressed the HIV-1 polyglycoprotein precursor, gp160, and the matur
e gp120-gp41 complex. When mixed with a CD4(+) T cell line (CEM), the
gp160-transfected cells mediated heterotypic cell fusion and formed mu
ltinucleate syncytia. Virus-neutralizing monoclonal antibodies to the
V2 and V3 domains of gp120 were able to inhibit syncytium formation, a
s were monoclonal antibodies to CD4. When ICAM-1 was coexpressed with
gp160, syncytium formation between the transfected kidney cells and un
infected CD$(+) T cells was markedly enhanced. Inhibitors of HIV-1 inf
ectivity (e.g., monoclonal antibodies to gp120, recombinant soluble CD
4) were able to prevent syncytium formation; however, the syncytium-bl
ocking activity of these agents was significantly attenuated in cultur
es in which ICAM-1 was cotransfected with gp160. These results confirm
that leukocyte adhesion molecules can promote gp160-mediated syncytiu
m formation and demonstrate, for the first time, that adhesive interac
tions mediated by ICAM-1 and its contrareceptor, LFA-1, attenuate the
syncytium-inhibiting activity of virus-neutralizing monoclonal antibod
ies and soluble CD4. These findings suggest that the type and magnitud
e of leukocyte adhesion molecules expressed on cells may be a signific
ant variable in in vitro HIV-1 neutralization assays.